• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic Malignancy.

作者信息

Gaba Ron C, Lokken R Peter, Hickey Ryan M, Lipnik Andrew J, Lewandowski Robert J, Salem Riad, Brown Daniel B, Walker T Gregory, Silberzweig James E, Baerlocher Mark Otto, Echenique Ana Maria, Midia Mehran, Mitchell Jason W, Padia Siddharth A, Ganguli Suvranu, Ward Thomas J, Weinstein Jeffrey L, Nikolic Boris, Dariushnia Sean R

机构信息

Division of Interventional Radiology, Department of Radiology, University of Illinois Hospital & Health Sciences System, 1740 West Taylor Street, MC 931, Chicago, IL 60612.

Division of Interventional Radiology, Department of Radiology, University of Illinois Hospital & Health Sciences System, 1740 West Taylor Street, MC 931, Chicago, IL 60612.

出版信息

J Vasc Interv Radiol. 2017 Sep;28(9):1210-1223.e3. doi: 10.1016/j.jvir.2017.04.025. Epub 2017 Jun 29.

DOI:10.1016/j.jvir.2017.04.025
PMID:
28669744
Abstract
摘要

相似文献

1
Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic Malignancy.经动脉化疗栓塞及肝恶性肿瘤栓塞的质量改进指南
J Vasc Interv Radiol. 2017 Sep;28(9):1210-1223.e3. doi: 10.1016/j.jvir.2017.04.025. Epub 2017 Jun 29.
2
Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy.肝恶性肿瘤经肝动脉化疗栓塞、栓塞及化疗灌注的质量改进指南。
J Vasc Interv Radiol. 2006 Feb;17(2 Pt 1):225-32. doi: 10.1097/01.RVI.0000195330.47954.48.
3
Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy.肝恶性肿瘤经肝动脉化疗栓塞、栓塞及化疗灌注的质量改进指南。
J Vasc Interv Radiol. 2012 Mar;23(3):287-94. doi: 10.1016/j.jvir.2011.11.029. Epub 2012 Jan 30.
4
Quality-improvement guidelines for hepatic transarterial chemoembolization.肝动脉化疗栓塞术的质量改进指南。
Cardiovasc Intervent Radiol. 2012 Aug;35(4):765-74. doi: 10.1007/s00270-012-0423-z. Epub 2012 May 31.
5
Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies.介入放射学会关于肝恶性肿瘤化疗栓塞的立场声明。
J Vasc Interv Radiol. 2006 Feb;17(2 Pt 1):217-23. doi: 10.1097/01.RVI.0000196277.76812.A3.
6
Re: Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies.主题：介入放射学会关于肝恶性肿瘤化疗栓塞的立场声明
J Vasc Interv Radiol. 2006 Jul;17(7):1209; author reply 1209-10. doi: 10.1097/01.RVI.0000223714.14073.44.
7
Transarterial chemoembolization for hepatocellular carcinoma.经动脉化疗栓塞治疗肝细胞癌。
J Am Coll Surg. 2006 Jan;202(1):155-68. doi: 10.1016/j.jamcollsurg.2005.06.263. Epub 2005 Oct 19.
8
Superselective Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma: Rationale, Technique, and Outcome.肝细胞癌的超选择性传统经动脉化疗栓塞术：原理、技术与结果
J Vasc Interv Radiol. 2016 Sep;27(9):1269-1278. doi: 10.1016/j.jvir.2016.04.014. Epub 2016 Jun 24.
9
Transarterial chemoembolisation is not superior to embolisation alone: the recent European Association for the Study of the Liver (EASL) - European Organisation for Research and Treatment of Cancer (EORTC) guidelines.经动脉化疗栓塞并不优于单纯栓塞：近期欧洲肝脏研究协会（EASL）-欧洲癌症研究与治疗组织（EORTC）指南。
Eur J Cancer. 2013 Apr;49(6):1509-10. doi: 10.1016/j.ejca.2012.11.012. Epub 2012 Dec 8.
10
Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis.经动脉化疗栓塞治疗原发性肝癌和结直肠癌肝转移
Surg Oncol Clin N Am. 2015 Jan;24(1):149-66. doi: 10.1016/j.soc.2014.09.004. Epub 2014 Oct 7.

引用本文的文献

1
Transarterial chemoembolization plus lenvatinib with or without protein-1 inhibitor for hepatocellular carcinoma with portal vein tumor thrombus.经动脉化疗栓塞联合乐伐替尼加或不加蛋白-1抑制剂治疗伴有门静脉癌栓的肝细胞癌
World J Clin Oncol. 2025 Jun 24;16(6):106798. doi: 10.5306/wjco.v16.i6.106798.
2
Transarterial Chemoembolization: A Consistent and Continuously Evolving Therapy for Hepatocellular Carcinoma.经动脉化疗栓塞术：一种针对肝细胞癌的持续且不断发展的治疗方法。
J Clin Exp Hepatol. 2025 Jul-Aug;15(4):102538. doi: 10.1016/j.jceh.2025.102538. Epub 2025 Mar 3.
3
Clinical and dosimetric considerations for yttrium-90 glass microspheres radioembolization of intrahepatic cholangiocarcinoma, metastatic colorectal carcinoma, and metastatic neuroendocrine carcinoma: recommendations from an international multidisciplinary working group.
钇-90玻璃微球放射性栓塞治疗肝内胆管癌、转移性结直肠癌和转移性神经内分泌癌的临床与剂量学考量：一个国际多学科工作组的建议
Eur J Nucl Med Mol Imaging. 2025 Mar 28. doi: 10.1007/s00259-025-07229-8.
4
Model Predicting Survival in Intermediate-Stage HCC Patients Reclassified for TACE Based on the 2022 BCLC Criteria.基于2022年BCLC标准重新分类为经动脉化疗栓塞术（TACE）的中期肝癌患者生存预测模型
Cancers (Basel). 2025 Mar 5;17(5):894. doi: 10.3390/cancers17050894.
5
Locoregional Therapies for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者肝细胞癌的局部区域治疗
Biomedicines. 2024 Sep 30;12(10):2226. doi: 10.3390/biomedicines12102226.
6
Adverse Event Rates in Interventional Radiology: A Review of 30 Years of Societal Quality Improvement Publications.介入放射学中的不良事件发生率：对30年社会质量改进出版物的综述
Cardiovasc Intervent Radiol. 2024 Dec;47(12):1687-1693. doi: 10.1007/s00270-024-03859-x. Epub 2024 Sep 30.
7
Applications of image-guided locoregional transarterial chemotherapy in patients with inoperable colorectal cancer: a review.影像引导下局部区域经动脉化疗在不可切除结直肠癌患者中的应用：综述
Front Oncol. 2024 Aug 23;14:1464242. doi: 10.3389/fonc.2024.1464242. eCollection 2024.
8
Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma.缺氧作为肝细胞癌经动脉化疗栓塞联合治疗的靶点
Pharmaceuticals (Basel). 2024 Aug 11;17(8):1057. doi: 10.3390/ph17081057.
9
Drug-eluting bead transarterial chemoembolization combined with apatinib/camrelizumab for the treatment of advanced hepatocellular carcinoma with hepatic arterioportal shunts.载药微球经动脉化疗栓塞联合阿帕替尼/卡瑞利珠单抗治疗合并肝动脉-门静脉分流的晚期肝细胞癌。
Br J Radiol. 2024 Dec 1;97(1164):1925-1930. doi: 10.1093/bjr/tqae166.
10
Efficacy and Safety of TACE Combined with Regorafenib versus TACE Combined with Camrelizumab in Hepatocellular Carcinoma With Untreatable Progression After TACE Combined with Sorafenib Therapy: A Case Control Study.TACE 联合瑞戈非尼与 TACE 联合卡瑞利珠单抗治疗索拉非尼联合 TACE 治疗后不可切除进展的肝细胞癌的疗效和安全性：一项病例对照研究。
Cancer Control. 2024 Jan-Dec;31:10732748241275004. doi: 10.1177/10732748241275004.